PT  - JOURNAL ARTICLE
AU  - Sulague, Ralf Martz
AU  - Beloy, Francis Joshua
AU  - Medina, Jillian Reeze
AU  - Mortalla, Edward Daniel
AU  - Cartojano, Thea Danielle
AU  - Macapagal, Sharina
AU  - Kpodonu, Jacques
TI  - Artificial Intelligence in Cardiac Surgery: A Systematic Review
AID  - 10.1101/2023.10.18.23297244
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.10.18.23297244
4099  - http://medrxiv.org/content/early/2023/10/19/2023.10.18.23297244.short
4100  - http://medrxiv.org/content/early/2023/10/19/2023.10.18.23297244.full
AB  - BACKGROUND Artificial intelligence has emerged as a tool to potentially increase efficiency and efficacy of healthcare and improve clinical outcomes. The growing body of knowledge of artificial intelligence applications in cardiac surgery necessitates evaluation of past studies to gain insights to the future direction of artificial intelligence applications in cardiac surgery. This study aims to provide a systematic review of the applications of artificial intelligence in cardiac surgery.METHODS A systematic literature search on artificial intelligence applications in cardiac surgery from 2000 to 2022 was conducted in the following databases: PubMed, Embase, Europe PMC, Epistemonikos, CINAHL, Cochrane Central, Google Scholar, Web of Science, Scopus, Cambridge Core, clinicaltrials.gov, and science. Studies on the implementation of artificial intelligence applications in cardiac surgery and the provision of decision support by the application through simulating clinical decision-making processes of healthcare providers were included. Studies not in English, published only as abstracts, review papers, meta-analyses, clinical trials that were still in progress, and published study protocols were excluded. This study was registered on Prospero (CRD42022377530).RESULTS A total of 42 studies were found that reported on artificial intelligence applications in cardiac surgery, all of which are cohort studies. Nine (21.43%) of the studies measured different parameters regarding cardiac surgeries in general. Meanwhile, 6 (14.29%) studies focused on Heart Transplantation (HT), 4 (9.52%) on Transcatheter Aortic Valve Replacement (TAVR), 3 (7.14%) anchored on Aortic Stenosis, and another 3 (7.14%) on Perioperative Complications. Three topics had 2 (4.76%) studies dedicated to them, namely Coronary Artery Bypass Graft (CABG), Postoperative Atrial Fibrillation (POAF), and Acute Kidney Injury (AKI). The remaining eleven studies have their own unique disease topics, procedures or surgeries in focus (n=11, 1 (2.38%), namely Postoperative Major Bleeding, Early Coronary Revascularization, Heart Valve Surgery, Isolated Mitral Valve Replacement (IMVR), Surgical Aortic Valve Replacement (SAVR), Open-Chest Surgery, Infective endocarditis, Post-Operative Deterioration, Red Blood Cell Transfusion, AKI - related Hippocampal Damage, and Open-Heart Surgery. Regarding evaluation outcomes, 26 studies examined the performance, 32 studies examined clinician outcomes, and 2 studies examined patient outcomes. Of the 42 studies, only 13 were conducted in Lower- and Middle-Income Countries.CONCLUSION Artificial intelligence was used to predict mortality, postoperative length of stay, and complications following cardiac surgeries. It can also improve clinicians’ medical decisions by providing better preoperative risk assessment, stratification, and prognostication. While the application of artificial intelligence in cardiac surgery has greatly progressed in the last two decades, more highly powered studies need to be done to assess challenges and to ensure accuracy and safety for use in clinical practice.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableAll relevant data are within the manuscript and its Supporting Information files.